8-bromoadenosine 3',5'-cyclic monophos-&, 8-bromoadenosine 3',5'-cyclic monophos-& and 2 more items

The University of Virginia awarded contract A207_PO-0248061-V3 to Sigma-Aldrich Inc on August 8, 2026, for the supply of specialized chemical and pharmaceutical products. The contract encompasses three distinct line items: 8-Bromoadenosine 3',5'-Cyclic Monophosphate, 3-Isobutyl-1-Methylxanthine (48 units), and Etoposide (74 units). The total contract value is $122, with delivery directed to the buyer. These materials are classified as research-grade chemicals commonly utilized in laboratory and pharmaceutical research applications.

Sigma-Aldrich Inc, the prime contractor, will fulfill this procurement in Virginia. The line items are priced at $1 per unit, reflecting what appears to be a specialized research supply arrangement. While the specific performance location is not explicitly detailed in the contract documentation, fulfillment is expected to occur in accordance with University of Virginia procurement standards. The contract award date of August 8, 2026, establishes the formal commencement of the supplier relationship for these chemical products.